These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 23910597

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Synthesis and biological evaluation of a novel series of aryl S,N-ketene acetals as antileishmanial agents.
    Suryawanshi SN, Kumar S, Tiwari A, Shivahare R, Chhonker YS, Pandey S, Shakya N, Bhatta RS, Gupta S.
    Bioorg Med Chem Lett; 2013 Jul 01; 23(13):3979-82. PubMed ID: 23673014
    [Abstract] [Full Text] [Related]

  • 4. Chemotherapy of leishmaniasis. Part IX: synthesis and bioevaluation of aryl substituted ketene dithioacetals as antileishmanial agents.
    Kumar S, Tiwari A, Suryawanshi SN, Mittal M, Vishwakarma P, Gupta S.
    Bioorg Med Chem Lett; 2012 Nov 01; 22(21):6728-30. PubMed ID: 23031588
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents.
    Marrapu VK, Mittal M, Shivahare R, Gupta S, Bhandari K.
    Eur J Med Chem; 2011 May 01; 46(5):1694-700. PubMed ID: 21385661
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and biological evaluation of new [1,2,4]triazino[5,6-b]indol-3-ylthio-1,3,5-triazines and [1,2,4]triazino[5,6-b]indol-3-ylthio-pyrimidines against Leishmania donovani.
    Gupta L, Sunduru N, Verma A, Srivastava S, Gupta S, Goyal N, Chauhan PM.
    Eur J Med Chem; 2010 Jun 01; 45(6):2359-65. PubMed ID: 20371140
    [Abstract] [Full Text] [Related]

  • 7. Triazino indole-quinoline hybrid: a novel approach to antileishmanial agents.
    Sharma R, Pandey AK, Shivahare R, Srivastava K, Gupta S, Chauhan PM.
    Bioorg Med Chem Lett; 2014 Jan 01; 24(1):298-301. PubMed ID: 24314395
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Structure based medicinal chemistry-driven strategy to design substituted dihydropyrimidines as potential antileishmanial agents.
    Rashid U, Sultana R, Shaheen N, Hassan SF, Yaqoob F, Ahmad MJ, Iftikhar F, Sultana N, Asghar S, Yasinzai M, Ansari FL, Qureshi NA.
    Eur J Med Chem; 2016 Jun 10; 115():230-44. PubMed ID: 27017551
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and evaluation of novel triazolyl quinoline derivatives as potential antileishmanial agents.
    Upadhyay A, Kushwaha P, Gupta S, Dodda RP, Ramalingam K, Kant R, Goyal N, Sashidhara KV.
    Eur J Med Chem; 2018 Jun 25; 154():172-181. PubMed ID: 29793211
    [Abstract] [Full Text] [Related]

  • 12. Chemotherapy of leishmaniasis part XIII: design and synthesis of novel heteroretinoid-bisbenzylidine ketone hybrids as antileishmanial agents.
    Tiwari A, Kumar S, Shivahare R, Kant P, Gupta S, Suryawanshi SN.
    Bioorg Med Chem Lett; 2015 Jan 15; 25(2):410-3. PubMed ID: 25475205
    [Abstract] [Full Text] [Related]

  • 13. Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agents.
    Gopinath VS, Pinjari J, Dere RT, Verma A, Vishwakarma P, Shivahare R, Moger M, Kumar Goud PS, Ramanathan V, Bose P, Rao MV, Gupta S, Puri SK, Launay D, Martin D.
    Eur J Med Chem; 2013 Nov 15; 69():527-36. PubMed ID: 24095747
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synthesis and in vitro antileishmanial activity of 5-substituted-2'-deoxyuridine derivatives.
    Peyron C, Benhida R, Bories C, Loiseau PM.
    Bioorg Chem; 2005 Dec 15; 33(6):439-47. PubMed ID: 16168460
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synthesis and evaluation of 2-pyridyl pyrimidines with in vitro antiplasmodial and antileishmanial activity.
    Musonda CC, Whitlock GA, Witty MJ, Brun R, Kaiser M.
    Bioorg Med Chem Lett; 2009 Jan 15; 19(2):401-5. PubMed ID: 19091562
    [Abstract] [Full Text] [Related]

  • 18. Chemotherapy of leishmaniasis. Part XII: design, synthesis and bioevaluation of novel triazole integrated phenyl heteroterpenoids as antileishmanial agents.
    Suryawanshi SN, Tiwari A, Kumar S, Shivahare R, Mittal M, Kant P, Gupta S.
    Bioorg Med Chem Lett; 2013 May 15; 23(10):2925-8. PubMed ID: 23582274
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.